Redox regulation of neuronal voltage-gated calcium channels

Antioxidants and Redox Signaling

Volumn 21, Issue 6, 2014, Pages 880-891

  Todorovic, Slobodan M ^a   Jevtovic Todorovic, Vesna ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CALCIUM CHANNEL T TYPE; CYSTEINE; FREE RADICAL; HOMOVANILLIC ACID; NITRIC OXIDE; NITROUS OXIDE; THIOCTIC ACID; TRACE METAL; VOLTAGE GATED CALCIUM CHANNEL; ANTIOXIDANT; CALCIUM; CALCIUM CHANNEL; ISOPROTEIN; METAL;

ACTION POTENTIAL; CALCIUM CURRENT; CHANNEL GATING; CHELATION; CURRENT CLAMP TECHNIQUE; ELECTRON TRANSPORT; HUMAN; HYPERALGESIA; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE DEPOLARIZATION; METAL BINDING; NERVE CELL; NEUROMODULATION; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; OSCILLATION; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PAIN RECEPTOR; PRIORITY JOURNAL; PROTEIN PROCESSING; RECEPTIVE FIELD; REGULATORY MECHANISM; REVIEW; SENSORY NERVE CELL; SPINAL GANGLION; THALAMUS NUCLEUS; THALAMUS RETICULAR NUCLEUS; WHOLE CELL PATCH CLAMP; ANIMAL; CATALYSIS; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIOXIDANTS; CALCIUM; CALCIUM CHANNELS; CALCIUM CHANNELS, T-TYPE; CATALYSIS; CYSTEINE; HUMANS; METALS; NEURONS; NITRIC OXIDE; OXIDATION-REDUCTION; PROTEIN ISOFORMS; THIOCTIC ACID;

EID: 84896547701     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5610     Document Type: Review

References (79)

1. Aley KO, McCarter G, and Levine JD. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J Neurosci 18: 7008-7014, 1998
2. Almanza A, Navarrete F, Vega R, and Soto E. Modulation of voltage-gated Ca2 + current in vestibular hair cells by nitric oxide. J Neurophysiol 97: 1188-1195, 2007
3. Aizenman E, Hartnett KA, and Reynolds IJ. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron 5: 841-846, 1990
4. Beenhakker MP and Huguenard JR. Neurons that fire together also conspire together: Is normal sleep circuitry hijacked to generate epilepsy?. Neuron 62: 612-632, 2009
5. Breustedt J, Vogt KE, Miller RJ, Nicoll RA, and Schmitz D. Alpha1E-containing Ca2 + channels are involved in synaptic plasticity. Proc Natl Acad Sci USA 100: 12450-12455, 2003
6. Bush AI. Copper, zinc, and the metallobiology of Alzheimer disease. Alzheimer Dis Assoc Disord 17: 147-150, 2003
7. Cameron NE, Jack AM, and Cotter MA. Effect of alphalipoic acid on vascular responses and nociception in Diabetic rats. Free Radic Biol Med 31: 125-135, 2001
8. Campbell JN and Meyer RA. Mechanisms of neuropathic pain. Neuron 52: 77-92, 2006
9. Carabelli V, D'Ascenzo M, Carbone E, and Grassi C. Nitric oxide inhibits neuroendocrine Ca(V)1 L-channel gating via cGMP-dependent protein kinase in cell-Attached patches of bovine chromaffin cells. J Physiol 541(Pt 2): 351-366, 2002
10. Carbone E and Lux HD. A low-voltage activated, fully inactivating Ca2 + channel in vertebrate sensory neurons. Nature 310: 501-502, 1984
11. Catterall WA. Structure and regulation of voltage-gated Ca2 + channels. Ann Rev Cell Dev Biol 16: 521-555, 2000
12. Catterall WA and Few AP. Calcium channel regulation and presynaptic plasticity. Neuron, 59: 882-901, 2008
13. Chen JY, Chang CY, Feng PH, Chu CC, So EC, and Hu ML. Plasma vitamin C is lower in postherpetic neuralgia patients and administration of vitamin C reduces spontaneous pain but not brush-evoked pain. Clin J Pain 25: 562-569, 2009
14. Cribbs LL, Lee JH, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M, Rees M, and Perez-Reyes E. Cloning and characterization of alpha1H from human heart, a member of the T-Type Ca2 + channel gene family. Circ Res 83: 103-109, 1998
15. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interv 4: 248-250, 2004
16. DePuy SD, Yao J, Hu C, McIntire W, Bidaud I, Lory P, Rastinejad F, Gonzalez C, Garrison JC, and Barrett PQ. The molecular basis for T-Type Ca2 + channel inhibition by G protein beta2gamma2 subunits. Proc Natl Acad Sci USA 103: 14590-14595, 2006
17. Gaston B. Nitric oxide and thiol groups. Biochem Biophya Acta 1411: 323-333, 1999
18. Gao X, Kim HK, Chung JM, and Chung K. Reactive oxygen species (ROS) are involved in enhancement of NMDAreceptor phosphorylation in animal models of pain. Pain 131: 262-271, 2007
19. Herrington J and Lingle CJ. Kinetic and pharmacological properties of low voltage-Activated Ca2 + current in rat clonal (GH3) pituitary cells. J Neurophysiol 68: 213-232, 1992
20. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, Rosenberg ER, Bayliss DA, Jevtovic-Todorovic V, and Todorovic SM. Cell-specific alterations of T-Type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27: 3305-3316, 2007
21. Jevtović-Todorović V, Todorović SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, and Olney JW. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4: 460-463, 1998
22. Joksovic PM, Bayliss DA, and Todorovic SM. Different kinetic properties of two T-Type Ca2 + currents of rat reticular thalamic neurons and their modulation by enflurane. J Physiol 566(Pt 1): 125-142, 2005
23. Joksovic PM, Brimelow BC, Murbartian J, Perez-Reyes E, and Todorovic SM. Contrasting anesthetic sensitivities of slow T-Type calcium channels of reticular thalamic neurons and recombinant Cav3.3 channels. Br J Pharmacol 144: 59-70, 2005
24. Joksovic PM, Doctor A, Gaston B, and Todorovic SM. Functional modulation of T-Type calcium channels by S-nitrosothiols in the rat thalamus. J Neurophys 97: 2712-2721, 2007
25. Joksovic PM, Nelson MT, Jevtovic-Todorovic V, Patel MK, Perez-Reyes E, Campbell KP, Chen C-C, and Todorovic SM. CaV3.2 is the major molecular substrate for redox regulation of T-Type Ca2 + channels in the rat and mouse thalamus. J Physiol 574: 415-430, 2006
26. Joksovic PM, Weiergräber M, Lee W, Struck H, Schneider T, and Todorovic SM. Isoflurane-sensitive presynaptic R-Type calcium channels contribute to inhibitory synaptic transmission in the rat thalamus. J Neurosci 29: 1434-1445, 2009
27. Kang HW, Vitko I, Lee SS, Perez-Reyes E, and Lee JH. Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-Type calcium channels. J Biol Chem 285: 3271-3281, 2010
28. Kawabata A, Ishiki T, Nagasawa K, Yoshida S, Maeda Y, Takahashi T, Sekiguchi F, Wada T, Ichida S, and Nishikawa H. Hydrogen sulfide as a novel nociceptive messenger. Pain 132: 74-81, 2007
29. Khosravani H and Zamponi GW. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86: 941-966, 2006
30. Lee J, Nelson MT, Rose KE, and Todorovic SM. Redox mechanisms of S-nirosothiol modulation of neuronal CaV3.2 T-Type calcium channels. Mol Neurobiol 48: 274-280, 2013
31. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klöckner U, Schneider T, and Perez-Reyes E. Cloning and expression of a novel member of the low voltage-Activated T-Type calcium channel family. J Neurosci 19: 1912-1921, 1999
32. Lee WY, Orestes P, Latham J, Naik AK, Nelson MT, Vitko I, Perez-Reyes E, Jevtovic-Todorovic V, and Todorovic SM. Molecular mechanisms of lipoic acid modulation of T-Type calcium channels in pain pathway. J Neurosci 29: 9500-9509, 2009
33. Lipton SA. Neuronal protection and destruction by NO. Cell Death Differ 6: 943-951, 1999
34. Luo ZD, Chaplan SR, Scott BP, Cizkova D, Calcutt NA, and Yaksh TL. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: Lack of a role in allodynia development. J Neurosci 19: 9201-9208, 1999
35. Mahapatra S, Calorio C, Vandael DHF, Marcantoni A, Carabelli V, and Carbone E. Calcium channel subtypes contributing to chromaffin cell excitability, exocytosis and endocytosis. Cell Calcium 51: 321-330, 2012
36. Maeda Y, Aoki Y, Sekiguchi F, Matsunami M, Takahashi T, Nishikawa H, and Kawabata A. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: Evidence for involvement of Cav3.2 T-Type calcium channels. Pain 142: 127-132, 2009
37. Mathie A, Sutton GL, Clarke CE, and Veale EL. Zinc and copper: Pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol Ther 111: 567-583, 2006
38. Matsunami M, Tarui T, Mitani K, Nagasawa K, Fukushima O, Okubo K, Yoshida S, Takemura M, and Kawabata A. Luminal hydrogen sulfide plays a pronociceptive role in mouse colon. Gut 58: 751-761, 2009
39. Memeo A and Loiero M. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: A randomized, double-blind, comparative study. Clin Drug Investig 28: 495-500, 2008
40. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, and Zorumski CF. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal culture. J Neurosci 18: 9716-9726, 1998
41. McCormick DA and Bal T. Sleep and arousal: Thalamocortical mechanisms. Annu Rev Neurosci 20: 185-215, 1997
42. McDonough SI, Swartz KJ, Mintz IM, Boland LM, and Bean BP. Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J Neurosci 16: 2612-2623, 1996
43. Mintz IM, Adams ME, and Bean BP. P-Type calcium channels in rat central and peripheral neurons. Neuron 9: 85-95, 1992
44. Nelson MT, Joksovic PM, Perez-Reyes E, and Todorovic SM. The endogenous redox agent L-cysteine induces T-Type Ca2 + channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J Neurosci 25:8766-8775, 2005
45. Nelson MT, Joksovic PM, Su P, Kang HW, Van Deusen A, Baumgart JP, David LS, Snutch TP, Barrett PQ, Lee JH, Zorumski CF, Perez-Reyes E, and Todorovic SM. Molecular mechanisms of subtype-specific inhibition of neuronal T-Type calcium channels by ascorbate. J Neurosci 27: 12577-12583, 2007
46. Nelson MT, Milescu LS, Todorovic SM, and Scroggs RS. A modeling study of T-Type Ca2 + channel gating and modulation by L-cysteine in rat nociceptors. Biophys J 98: 197-206, 2010
47. Nelson MT, Woo J, Kang HW, Vitko I, Barrett PQ, Perez-Reyes E, Lee JH, Shin HS, and Todorovic SM. Reducing agents sensitize C-Type nociceptors by relieving high-Affinity zinc inhibition of T-Type calcium channels. J Neurosci 27: 8250-8260, 2007
48. Nishimura S, Fukushima O, Ishikura H, Takahashi T, Matsunami M, Tsujiuchi T, Sekiguchi F, Naruse M, Kamanaka Y, and Kawabata A. Hydrogen sulfide as a novel mediator for pancreatic pain in rodents. Gut 58: 762-770, 2009
49. Nishiyama T and Ogawa M. Intrathecal edaravone, a free radical scavenger, is effective on inflammatoryinduced pain in rats. Acta Anaesthesiol Scand 49: 147-151, 2005
50. Okubo K, Nakanishi H, Matsunami M, Shibayama H, and Kawabata A. Topical application of disodium isostearyl 2-OL-Ascorbyl phosphate, an amphiphilic ascorbic acid derivative, reduces neuropathic hyperalgesia in rats. Br J Pharmacol 166: 1058-1068, 2012
51. Orestes P, Bojadzic D, Lee J, Leach E, Salajegheh R, Digruccio MR, Nelson MT, and Todorovic SM. Free radical signaling underlies inhibition of CaV3.2 T-Type calcium channels by nitrous oxide in the pain pathway. J Physiol 589(Pt 1): 135-148, 2011
52. Ozawa H, Chancellor MB, Jung SK, Yokoyama T, Fraser MO, Yu Y, de Groat WC, and Yoshimura N Effects of intravesical nitric oxide therapy on cyclophosphamideinduced cystitis. J Urol 163: 2211-2216, 1999
53. Pathirathna S, Covey DF, Todorovic SM, and Jevtovic-Todorovic V. Differential effects of endogenous cysteine analogs on peripheral thermal nociception in intact rats. Pain 125: 53-64, 2006
54. Perez-Reyes E. Molecular physiology of low-voltageactivated T-Type calcium channels. Physiol Rev 83:117-161, 2003
55. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, and Lee JH. Molecular characterization of a neuronal low-voltage-Activated T-Type calcium channel. Nature 391: 896-900, 1998
56. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci 23: 209-216, 2000
57. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, Currie MG, Cuzzocrea S, Sikorski JA, and Riley DP. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 286: 304-306, 1999
58. Smith AR, Shenvi SV, Widlansky M, Suh JH, and Hagen TM. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 11: 1135-1146, 2004
59. Smith SD, Wheeler MA, Foster HE, and Weiss RM. Improvement in interstitial cystitis symptom scores during treatment with oral L-Arginine. J Urol 158: 703-708, 1997
60. Stadtman ER. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu Rev Biochem 62: 797-821, 1993
61. Stamler JS, Lamas S, and Fang FC. Nitrosylation: The prototypic redox-based signaling mechanism. Cell 106: 675-683, 2001
62. Steriade M. Sleep, epilepsy and thalamic reticular inhibitory neurons. Trends Neurosci 28: 317-324, 2005
63. Steriade M, Deschenes M, Domich L, and Mulle C. Abolition of spindle oscillations in thalamic neurons disconnected from nucleus reticularis thalami. J Neurophysiol 54: 1473-1497, 1985
64. Strausak D, Mercer JF, Dieter HH, Stremmel W, and Multhaup G. Copper in Disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson Diseases. Brain Res Bull 55: 175-185, 2001
65. Takahashi T, Aoki Y, Okubo K, Maeda Y, Sekiguchi F, Mitani K, Nishikawa H, and Kawabata A. Upregulation of Ca(v)3.2 T-Type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain. Pain 150: 183-191, 2010
66. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E, and Bayliss DA. Differential distribution of three members of a gene family encoding low voltage-Activated (T-Type) calcium channels. J Neurosci 19: 1895-1911, 1999
67. Todorovic SM and Lingle CJ. Pharmacological properties of T-Type Ca2 + current in adult rat sensory neurons: Effects of anticonvulsant and anesthetic agents. J Neurophysiol 79: 240-252, 1998
68. Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C, Olney JW, and Zorumski CF. Redox modulation of T-Type calcium channels in rat peripheral nociceptors. Neuron 31: 75-85, 2001
69. Todorovic SM, Jevtovic-Todorovic V, Mennerick S, Perez-Reyes E, and Zorumski CF. Cav3.2 channels is a molecular substrate for inhibition of T-Type calcium currents in rat sensory neurons by nitrous oxide. Mol Pharmacol 60: 603-610, 2001
70. Todorovic SM, Meyenburg A, and Jevtovic-Todorovic V. Redox modulation of T-Type calcium channels in vivo: Alteration of nerve injury-induced thermal hyperalgesia. Pain 109: 328-339, 2004
71. Tottene A, Volsen S, and Pietrobon D. alpha(1E) subunits form the pore of three cerebellar R-Type calcium channels with different pharmacological and permeation properties. J Neurosci 20: 171-178, 2000
72. Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, and Lory P. Subunit-specific modulation of T-Type calcium channels by zinc. J Physiol 578(Pt 1): 159-171, 2007
73. Usunoff KG, Kharazia VN, Valtschanoff JG, Schmidt HH, and Weinberg RJ. Nitric oxide synthase-containing projections to the ventrobasal thalamus in the rat. Anat Embryol (Berl) 200: 265-281, 1999
74. White G, Lovinger DM, and Weight FF. Transient lowthreshold Ca2 + current triggers burst firing through an afterdepolarizing potential in an adult mammalian neuron. Proc Natl Acad Sci USA 86: 6802-6806, 1989
75. Wolfe JT, Wang H, Howard J, Garrison JC, and Barrett PQ. T-Type calcium channel regulation by specific G-protein betagamma subunits. Nature 424: 209-213, 2003
76. Wu LG and Saggau P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20: 204-212, 1997
77. Wu LG, Borst JG, and Sakmann B. R-Type Ca2 + currents evoke transmitter release at a rat central synapse. Proc Natl Acad Sci USA 95: 4720-4725, 1998
78. Yoshimura N, Seki S, and de Groat WC. Nitric oxide modulates Ca2 + channels in Dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 86: 304-311, 2001
79. Zollinger PE, Tuinebreijer WE, Breederveld RS, and Kreis RW. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures?. A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am 89: 1424-1431, 2007.